ART makes move to commercialize breast imaging device in Canada

ART Advanced Research Technologies Inc. last week announced that it has filed a Medical Device License Application with Health Canada to begin the commercialization of its SoftScan breast imaging device.

ART is seeking regulatory approval of SoftScan as an adjunct to x-ray mammography.  It uses a non-invasive and pain-free approach based on time-domain optical imaging technology which will enable the characterization of breast tumors by clinicians as benign or malignant, without exposing the patients to potentially harmful radiation, the company said.